TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Former Group Chair Responds To Niederhuber: Change But Don’t Dissolve Cooperative Groups July 2, 2010